Substance use disorders. Other psychoactive substance abuse
Conditions
Interventions
Intervention 1: Control group: This group receives the conventional interventions of drug cessation centers. Treatment measures of withdrawal centers in our country are usually prescription of agonis
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Absence of central nervous system diseases (stroke, multiple sclerosis, Parkinson's, etc., according to observations and medical records) Minimum period of abstinence from any substance and alcohol for a period of 15 days Age range of 18-50 years Absence of any psychiatric diagnosis based on DSM-5 diagnostic criteria Absence of obvious movement problems (according to observation and medical record) No history of head injury with loss of consciousness or seizures (according to observation and medical record) Not taking drugs that disrupt the central nervous system (medical history and doctor's confirmation)
Exclusion criteria
Exclusion criteria: Substance abuse The person's unwillingness to answer questions or attend the intervention session Receive cognitive rehabilitation treatments at the same time
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Occupational balance score. Timepoint: 1- Before the start of the intervention, 2- After the end of the interventions, 3- After the two-month follow-up period. Method of measurement: Occupational balance questionnaire.;Occupational performance score. Timepoint: 1- Before the start of the intervention, 2- After the end of the interventions, 3- After the two-month follow-up period. Method of measurement: Occupational performance questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Leisure score. Timepoint: 1- Before the start of the intervention, 2- After the end of the interventions, 3- After the two-month follow-up period. Method of measurement: Leisure time questionnaire.;Quality of life score. Timepoint: 1- Before the start of the intervention, 2- After the end of the interventions, 3- After the two-month follow-up period. Method of measurement: Quality of life questionnaire(36-Item Short-Form Health Survey).;Drug craving score. Timepoint: 1- Before the start of the intervention, 2- After the end of the interventions, 3- After the two-month follow-up period. Method of measurement: Drug desire questionnaire.;Executive function score. Timepoint: 1- Before the start of the intervention, 2- After the end of the interventions, 3- After the two-month follow-up period. Method of measurement: Dysexecutive questionnaire.;Time management score. Timepoint: 1- Before the start of the intervention, 2- After the end of the interventions, 3- After the two-month follow-up period. Method of measurement: Assessment of Time management skills questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Malahat Akbafahimi
Iran University of Medical Sciences
Outcome results
None listed